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Abstract 
This study is aimed at elucidating the structure of a novel T-cell adhesion inhibitor, 
cyclo(1,8)-CPRGGSVC using one- and two-dimensional 1H NMR and molecular dynamics 
(MD) simulation. The peptide is derived from the sequence of its parent peptide cIBR 
(cyclo(1,12)-PenPRGGSVLVTGC), which is a fragment of intercellular adhesion molecule-1 
(ICAM-1). Our previous results show that the cyclo(1,8)-CPRGGSVC peptide binds to the 
LFA-1 I-domain and inhibits heterotypic T-cell adhesion, presumably by blocking the LFA-
1/ICAM-1 interactions. The structure of the peptide was determined using NMR and MD 
simulation in aqueous solution. Our results indicate that the peptide adopts type-I β-turn 
conformation at the Pro2-Arg3-Gly4-Gly5 (PRGG) sequence. The β-turn structure at the 
PRGG motif is well conserved in cIBR peptide and ICAM-1 receptor, which suggests the 
importance of the PRGG motif for the biological activity of cyclo(1,8)-CPRGGSVC peptide. 
Meanwhile, the Gly5-Ser6-Val7-Cys8-Cys1 (GSVCC) sequence forms a “turn-like” random 
coil structure that does not belong to any structured motif. Therefore, cyclo(1,8)-CPRGGSVC 
peptide has only one structured region at the PRGG sequence, which may play an important 
role in the binding of the peptide to the LFA-1 I-domain. The conserved β-turn conformation 
of the PRGG motif in ICAM-1, cIBR, and cyclo(1,8)-CPRGGSVC peptides can potentially 
be used to design peptidomimetics. 
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